Next |
home / stock / amph / amph message board
Subject | By | Source | When |
---|---|---|---|
AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITIES$AMPHExcited to share an article about | | mwn | 03/12/2023 9:32:53 PM |
I've bought some $AMPH at $31. Great products | Gentlemen Prefer Bonds | investorshub | 06/29/2022 5:36:36 PM |
$AMPH buy 42.3299 | stocktrademan | investorshub | 04/17/2022 8:52:53 AM |
$AMPH 50/200sma crossed here...Nice bullish sign. | Golden Cross | investorshub | 06/24/2020 10:05:50 PM |
fda approval | atarabih | investorshub | 06/09/2020 10:22:00 AM |
Gearing up for another amazing surprise quarter of | MakeABuck2000 | investorshub | 01/12/2018 6:54:47 PM |
reading my friend, their drug helper going on | mick | investorshub | 11/10/2017 8:23:12 PM |
China has several generic-insulin products already on the market. | DewDiligence | investorshub | 03/18/2017 3:00:55 PM |
Do you see them investing in China to | Phaeton | investorshub | 03/18/2017 12:47:29 PM |
Squeezing up! I love it | Jess070283 | investorshub | 03/17/2017 4:46:36 PM |
Momenta, Sandoz allowed to broaden claims over quality | floblu14 | investorshub | 06/29/2016 4:40:25 PM |
AMPH is not a start-up, but it has | DewDiligence | investorshub | 05/13/2015 9:40:07 PM |
Update on Lovenox patent case: #msg-113632332. | DewDiligence | investorshub | 05/13/2015 9:38:27 PM |
No issue. | Phaeton | investorshub | 12/05/2014 3:52:30 AM |
IT IS 32 MILLION FROM NOW TO END | TREND1 | investorshub | 12/04/2014 5:47:09 PM |
They did give a number for their MANNKIND | Phaeton | investorshub | 12/04/2014 1:40:08 PM |
You just did not hear it .... | TREND1 | investorshub | 12/04/2014 2:42:24 AM |
They did not give any dollar figure for | Phaeton | investorshub | 12/04/2014 2:40:18 AM |
This EPS info is wrong. | TREND1 | investorshub | 12/04/2014 1:19:14 AM |
Phaeton Did you catch only 32 million sales to | TREND1 | investorshub | 12/04/2014 1:17:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will hold a conference call to discuss its...
2024-04-29 08:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the ...